{
  "run_id": "RUN_20260203_174258_0a58abccb18d",
  "timestamp": "2026-02-03T22:30:41.849939",
  "document": "Central-Core-Disease.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/test/Central-Core-Disease.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 1,
  "total_validated": 1,
  "total_rejected": 0,
  "total_investigational": 0,
  "drugs": [
    {
      "matched_text": "anesthetic drugs",
      "preferred_name": "Anesthetics",
      "brand_name": null,
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": null,
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": null,
      "route": null,
      "marketing_status": null,
      "codes": {
        "rxcui": null,
        "mesh": "D000077442",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "UMLS_CUI",
          "code": "C0002932",
          "display": "Anesthetics"
        },
        {
          "system": "MeSH",
          "code": "D000077442",
          "display": "Lidocaine Prilocaine Drug Combination"
        }
      ],
      "context": "e individuals with CCD may be susceptible to developing malignant hyperthermia, a condition in which individuals develop adverse reactions to certain anesthetic drugs. CCD may be very mild or may cause serious complications. Most cases are inherited as autosomal dominant trait and associated with nonprogressive mus",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "ner:scispacy_umls",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Lidocaine Prilocaine Drug Combination",
      "enrichment_source": "pubtator3"
    }
  ]
}